The Major Histocompatibility Complex–related Fc Receptor for IgG (FcRn) Binds Albumin and Prolongs Its Lifespan

Cited by (642)

Items 201–300 of 642

1. The glomerular filter: an imperfect barrier is required for perfect renal function
   Wayne Doveton Comper, Leileata M. Russo · 2009 · Current Opinion in Nephrology & Hypertension
2. Blood-derived proteins in milk at start of lactation: Indicators of active or passive transfer
   Samantha K. Wall, J.J. Gross, E.C. Kessler, Kris Villez, R.M. Bruckmaier · 2015 · Journal of Dairy Science
3. Striking a Balance between Carbonate/Carbamate Linkage Bond- and Reduction-Sensitive Disulfide Bond-Bearing Linker for Tailored Controlled Release: In Situ Covalent-Albumin-Binding Gemcitabine Prodrugs Promote Bioavailability and Tumor Accumulation
   Huicong Zhang, Kuanglei Wang, Kexin Na, Dan Li, Zhenbao Li, Dongyang Zhao, Lu Zhong, Menglin Wang, Longfa Kou, Cong Luo et al. · 2018 · Journal of Medicinal Chemistry
4. Neonatal Fc receptor – biology and therapeutics
   Bussel, James B., Cines, Douglas B., Blumberg, Richard S. · 2025 · New England Journal of Medicine
5. Neonatal Fc Receptor–Targeted Therapies in Neurology
   Christopher Nelke, Marianna Spatola, Christina B. Schroeter, Heinz Wiendl, Jan D. Lünemann · 2022 · Neurotherapeutics
6. The neonatal Fc receptor is expressed by human retinal pigment epithelial cells and is downregulated by tumour necrosis factor-alpha
   Kiki van Bilsen, P. Martin van Hagen, Jeroen Bastiaans, Jan C. van Meurs, Tom Missotten, Robert W. A. M. Kuijpers, Herbert Hooijkaas, Gemma M. Dingjan, G. Seerp Baarsma, Willem A. Dik · 2011 · British Journal of Ophthalmology
7. In vivo depletion of serum IgG by an affibody molecule binding the neonatal Fc receptor
   Johan Seijsing, Shengze Yu, Fredrik Y. Frejd, Ingmarie Höidén‐Guthenberg, Torbjörn Gräslund · 2018 · Scientific Reports
8. Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion
   Mengyuan Liu, Yi Huang, Lei Hu, Guoping Liu, Xueping Hu, Dongxu Liu, Xiaosong Yang · 2012 · BMC Biotechnology
9. Heterogeneity of proteome dynamics between connective tissue phases of adult tendon
   Deborah Simpson, Howard Choi, Ding Wang, Mark C. Prescott, Andrew A. Pitsillides, Jayesh Dudhia, Peter Clegg, Peipei Ping, Chavaunne T. Thorpe · 2020 · eLife
10. Generation of a double transgenic humanized neonatal Fc receptor (FcRn)/albumin mouse to study the pharmacokinetics of albumin-linked drugs
    Dorthe Viuff, Filipa Antunes, Leslie R. Evans, Jason Cameron, Hans Dyrnesli, Birgitte Thue Ravn, Magnus Stougaard, Kader Thiam, Birgitte Andersen, Søren Kjærulff et al. · 2015 · Journal of Controlled Release
11. Human Epidermal Growth Factor Receptor 3–Specific Tumor Uptake and Biodistribution of89Zr-MSB0010853 Visualized by Real-Time and Noninvasive PET Imaging
    Frank J. Warnders, Anton G.T. Terwisscha van Scheltinga, Christine Knuehl, Maarten Van Roy, Erik F. J. de Vries, Jos G. W. Kosterink, Elisabeth G.E. de Vries, Marjolijn N. Lub–de Hooge · 2017 · Journal of Nuclear Medicine
12. Dissection of the Neonatal Fc Receptor (FcRn)-Albumin Interface Using Mutagenesis and Anti-FcRn Albumin-blocking Antibodies
    Kine Marita Knudsen Sand, Bjørn Dalhus, Gregory J. Christianson, Malin Bern, Stian Foss, Jason Cameron, Darrell Sleep, Magnar Bjørås, Derry C. Roopenian, Inger Sandlie et al. · 2014 · Journal of Biological Chemistry
13. Controversies regarding albumin therapy in cirrhosis
    Jonel Trebicka, Guadalupe García–Tsao · 2023 · Hepatology
14. Antimicrobial Peptides: Current Status, Mechanisms of Action, and Strategies to Overcome Therapeutic Limitations
    Seong Hwan Kim, Yu-Hong Min, Min‐Chul Park · 2025 · Microorganisms
15. Translational Pharmacokinetics and Pharmacodynamics of an FcRn-Variant Anti-CD4 Monoclonal Antibody From Preclinical Model to Phase I Study
    Yanan Zheng, Heleen Scheerens, John C. Davis, Rong Deng, Saloumeh Kadkhodayan Fischer, Cynthia Woods, Paul J. Fielder, Eric Gary Stefanich · 2010 · Clinical Pharmacology & Therapeutics
16. Antidiabetic effect of S-allylcysteine: Effect on Thyroid hormone and circulatory antioxidant system in experimental diabetic rats
    Ganapathy Saravanan, P. Ponmurugan · 2012 · Journal of Diabetes and its Complications
17. Cross-presentation of IgG-containing immune complexes
    Kristi Baker, Timo Räth, Wayne I. Lencer, Edda Fiebiger, Richard S. Blumberg · 2012 · Cellular and Molecular Life Sciences
18. Insight into small molecule binding to the neonatal Fc receptor by X-ray crystallography and 100 kHz magic-angle-spinning NMR
    Daniel Friedrich, Alex Macpherson, Susanne A. Penzel, Nicolas Basse, Fabien Lecomte, Hervé Deboves, Richard D. Taylor, Tim Norman, John R. Porter, Lorna C. Waters et al. · 2018 · PLoS Biology
19. FcRn overexpression in human cancer drives albumin recycling and cell growth; a mechanistic basis for exploitation in targeted albumin-drug designs
    Maja Thim Larsen, Ole Aalund Mandrup, Karen Kræmmer Schelde, Yonglun Luo, Karina Dalsgaard Sørensen, Frederik Dagnæs‐Hansen, Jason Cameron, Magnus Stougaard, Torben Steiniche, Kenneth Alan Howard · 2020 · Journal of Controlled Release
20. Fc gamma receptor IIb participates in maternal IgG trafficking of human placental endothelial cells
    Tomoko Ishikawa, Takami Takizawa, Jun Iwaki, Takuya Mishima, Kumiko Ui‐Tei, Toshiyuki Takeshita, Shigeki Matsubara, Toshihiro Takizawa · 2015 · International Journal of Molecular Medicine
21. Tuning the serum persistence of human serum albumin domain III:diabody fusion proteins
    Vania E. Kenanova, Tove Olafsen, Felix B. Salazar, Lawrence E. Williams, Scott M. Knowles, Anna M. Wu · 2010 · Protein Engineering Design and Selection
22. The in vivo fates of plant viral nanoparticles camouflaged using self-proteins: overcoming immune recognition
    Neetu M. Gulati, Andrzej S. Pitek, Anna E. Czapar, Phoebe L. Stewart, Nicole F. Steinmetz · 2018 · Journal of Materials Chemistry B
23. Cell surface dynamics and cellular distribution of endogenous FcRn
    D’Hooghe, Lena, Chalmers, Andrew D., Heywood, Sam, Whitley, Paul · 2017 · PLOS ONE
24. Influence of size and charge of unstructured polypeptides on pharmacokinetics and biodistribution of targeted fusion proteins
    Fabian Brandl, Hannes Merten, Martina Zimmermann, Martin P Béhé, Uwe Zangemeister‐Wittke, Andreas Plückthun · 2019 · Journal of Controlled Release
25. FcRn mediates fast recycling of endocytosed albumin and IgG from early macropinosomes in primary macrophages
    Wei Hong Toh, Jade Louber, Ismail Sami Mahmoud, Jenny Chia, Greg Bass, Steven Dower, Anne M. Verhagen, Paul A. Gleeson · 2019 · Journal of Cell Science
26. Systematic interaction of plasma albumin with the efficacy of chemotherapeutic drugs
    Liuchunyang Yu, Zhenglai Hua, Xinyi Luo, Ting Zhao, Yuanyan Liu · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
27. Adsorbed serum albumin is permissive to macrophage attachment to perfluorocarbon polymer surfaces in culture
    Marisha L. Godek, R. Michel, Lisa M. Chamberlain, David G. Castner, David W. Grainger · 2008 · Journal of Biomedical Materials Research Part A
28. Generation of therapeutic protein variants with the human serum albumin binding capacity via site-specific fatty acid conjugation
    Jinhwan Cho, Sung In Lim, Byungseop Yang, Young S. Hahn, Inchan Kwon · 2017 · Scientific Reports
29. Triple (GGTA1, CMAH, B2M) modified pigs expressing an SLA class Ilow phenotype—Effects on immune status and susceptibility to human immune responses
    Rabea Hein, Hendrik Johannes Sake, Claudia Pokoyski, Joachim Hundrieser, Antje Brinkmann, Wiebke Baars, Monika Nowak‐Imialek, Andrea Lucas‐Hahn, Constança Figueiredo, Hans‐Joachim Schuberth et al. · 2019 · American Journal of Transplantation
30. Interleukin 2-Based Fusion Proteins for the Treatment of Cancer
    Alana MacDonald, T.‐C. Wu, Chien‐Fu Hung · 2021 · Journal of Immunology Research
31. DNA Adduct Formation by 2,6-Dimethyl-, 3,5-Dimethyl-, and 3-Ethylaniline in Vivo in Mice
    Paul L. Skipper, Laura J. Trudel, Thomas W. Kensler, John D. Groopman, Patricia A. Egner, Rosa G. Liberman, Gerald N. Wogan, Steven R. Tannenbaum · 2006 · Chemical Research in Toxicology
32. Hematopoietic cells as site of first-pass catabolism after subcutaneous dosing and contributors to systemic clearance of a monoclonal antibody in mice
    Richter, Wolfgang F., Christianson, Gregory J., Frances, Nicolas, Grimm, Hans Peter, Proetzel, Gabriele, Roopenian, Derry C. · 2018 · mAbs
33. Nipocalimab, an immunoselective FcRn blocker that lowers IgG and has unique molecular properties
    Nilufer P. Seth, Rui Xu, Matthew L. DuPrie, Amit Choudhury, Sam Sihapong, Steven Tyler, James W. Meador, William Avery, Edward D. Cochran, Thomas M. Daly et al. · 2025 · mAbs
34. Improved kinetics of rIX‐FP, a recombinant fusion protein linking factor IX with albumin, in cynomolgus monkeys and hemophilia B dogs
    Marc Wolfgang Nolte, Timothy C. Nichols, Jochen Mueller‐Cohrs, Elizabeth P. Merricks, Ingo Pragst, Sabine Zollner, Gerhard Dickneite · 2012 · Journal of Thrombosis and Haemostasis
35. Near-Infrared Imaging of Injured Tissue in Living Subjects Using IR-820
    Suresh I. Prajapati, Carlo O. Martinez, Ali N. Bahadur, Isabel Q. Wu, Wei Zheng, James Donald Lechleiter, Linda M. McManus, Gary B. Chisholm, Joel Edmund Michalek, Paula Kay Shireman et al. · 2009 · Molecular Imaging
36. Smart Stimuli-Responsive Biopolymeric Nanomedicines for Targeted Therapy of Solid Tumors
    Marziyeh Fathi, Elaheh Dalir Abdolahinia, Jaleh Barar, Yadollah Omidi · 2020 · Nanomedicine
37. 1,5-Anhydroglucitol and Glycated Albumin in Glycemia
    Masafumi Koga · 2014 · Advances in clinical chemistry
38. NANOG Decoy Oligodeoxynucleotide–Encapsulated Niosomes Nanocarriers: A Promising Approach to Suppress the Metastatic Properties of U87 Human Glioblastoma Multiforme Cells
    Mahmoud Gharbavi, Behrooz Johari, Elham Rismani, Navid Mousazadeh, Amir Hossein Taromchi, Ali Sharafi · 2020 · ACS Chemical Neuroscience
39. Neonatal Fc Receptor Promotes Immune Complex–Mediated Glomerular Disease
    Florina Olaru, Wentian Luo, Hani Y. Suleiman, Patricia L. St. John, Linna Ge, Adam R. Mezo, Andréy S. Shaw, Dale R. Abrahamson, Jeffrey H. Miner, Dorin‐Bogdan Borza · 2013 · Journal of the American Society of Nephrology
40. Quantitative Analysis of Human Neonatal Fc Receptor (FcRn) Tissue Expression in Transgenic Mice by Online Peptide Immuno-Affinity LC-HRMS
    Yao‐Yun Fan, Hendrik Neubert · 2016 · Analytical Chemistry
41. Characterization of Human Serum Albumin isoforms by ion exchange chromatography coupled on-line to native mass spectrometry
    Y. Leblanc, Nicolas Bihoreau, Guillaume Chevreux · 2018 · Journal of Chromatography B
42. Cellular recycling-driven in vivo half-life extension using recombinant albumin fusions tuned for neonatal Fc receptor (FcRn) engagement
    Maja Thim Larsen, Helen Rawsthorne, Karen Kræmmer Schelde, Frederik Dagnæs‐Hansen, Jason Cameron, Kenneth Alan Howard · 2018 · Journal of Controlled Release
43. A Trojan-Horse Strategy by In Situ Piggybacking onto Endogenous Albumin for Tumor-Specific Neutralization of Oncogenic MicroRNA
    Gijung Kwak, Hyo‐Suk Kim, Jooho Park, Eun Hye Kim, Hochung Jang, Geonhee Han, Sun Young Wang, Yoosoo Yang, Ick Chan Kwon, Sun Hwa Kim · 2021 · ACS Nano
44. FcRn expression in cancer: Mechanistic basis and therapeutic opportunities
    Imke Rudnik‐Jansen, Kenneth Alan Howard · 2021 · Journal of Controlled Release
45. Tendon Extracellular Matrix Assembly, Maintenance and Dysregulation Throughout Life
    Seyed Mohammad Siadat, Danae E. Zamboulis, Chavaunne T. Thorpe, Jeffrey W. Ruberti, Brianne K. Connizzo · 2021 · Advances in experimental medicine and biology
46. An Albumin-binding Polypeptide Both Targets Cytotoxic T Lymphocyte Vaccines to Lymph Nodes and Boosts Vaccine Presentation by Dendritic Cells
    Peng Wang, Peng Zhao, Shuyun Dong, Tiefeng Xu, Xiao He, Mingnan Chen · 2017 · Theranostics
47. Molecularly Engineered Nanobodies for Tunable Pharmacokinetics and Drug Delivery
    Patrick M. Glassman, Landis R. Walsh, Carlos H. Villa, Oscar Armando Marcos-Contreras, Elizabeth D. Hood, Vladimir R. Muzykantov, Colin F. Greineder · 2020 · Bioconjugate Chemistry
48. IgG transmitted from allergic mothers decreases allergic sensitization in breastfed offspring
    Adam P. Matson, Roger S. Thrall, Ektor Rafti, Elizabeth G. Lingenheld, Lynn Puddington · 2010 · Clinical and Molecular Allergy
49. Identification of prognostic nutritional index as a reliable prognostic indicator for advanced lung cancer patients receiving immune checkpoint inhibitors
    Xuebing Yan, Jiaxin Wang, Jingxian Mao, Ying Wang, Xiangjun Wang, Mengxue Yang, Hong Qiao · 2023 · Frontiers in Nutrition
50. Therapeutic Potential of Inorganic Nanoparticles for the Delivery of Monoclonal Antibodies
    Christopher T. Turner, Steven J. P. McInnes, Nicolas Hans Voelcker, Allison June Cowin · 2015 · Journal of Nanomaterials
51. Development of long-acting recombinant FVIII and FIX Fc fusion proteins for the management of hemophilia
    Amy D. Shapiro · 2013 · Expert Opinion on Biological Therapy
52. Mechanism of increased clearance of glycated albumin by proximal tubule cells
    Mark C. Wagner, Jered Myslinski, Shiv Pratap Singh Yadav, Brittany N. Flores, George J. Rhodes, Sílvia B. Campos, Ruben M. Sandoval, Sudhanshu Kumar, Monika Patel, Ashish et al. · 2016 · American Journal of Physiology-Renal Physiology
53. Review Article: Albumin and Its Role in Inflammatory Bowel Disease: The Old, the New, and the Future
    Karla Cameron, Anke L. Nguyen, David J Gibson, Mark G. Ward, Miles Sparrow, Peter R. Gibson · 2025 · Journal of Gastroenterology and Hepatology
54. Intranasal Administration of Antibody-Bound Respiratory Syncytial Virus Particles Efficiently Primes Virus-Specific Immune Responses in Mice
    Debby Kruijsen, H Einarsdottir, Marcel A. Schijf, Frank E. J. Coenjaerts, C. Ellen van der Schoot, Gestur Vidarsson, Grada M. van Bleek · 2013 · Journal of Virology
55. Localization of the human neonatal Fc receptor (FcRn) in human nasal epithelium
    Heidl, Sara, Ellinger, Isabella, Niederberger, Verena, Waltl, Eva E., Fuchs, Renate · 2016 · Protoplasma
56. Half-life–extended recombinant coagulation factor IX–albumin fusion protein is recycled via the FcRn-mediated pathway
    Jenny Chia, Jade Louber, Isabelle Glauser, Shirley Taylor, Greg Bass, Steven Dower, Paul A. Gleeson, Anne M. Verhagen · 2018 · Journal of Biological Chemistry
57. Aggregates of IVIG or Avastin, but not HSA, modify the response to model innate immune response modulating impurities
    Swamy Kumar Polumuri, Lydia Asrat Haile, Derek D.C. Ireland, Daniela I. Verthelyi · 2018 · Scientific Reports
58. Computer-assembled cross-species/cross-modalities two-pore physiologically based pharmacokinetic model for biologics in mice and rats
    Armin Sepp, Guy M. L. Meno‐Tetang, Andrew D. Weber, Andrew Sanderson, Oliver Schön, Aliénor Berges · 2019 · Journal of Pharmacokinetics and Pharmacodynamics
59. Tuning protein half-life in mouse using sequence-defined biopolymers functionalized with lipids
    Koen Vanderschuren, Pol Arranz‐Gibert, Minsoo Khang, Hadar Dagan, Alice Gaudin, Fan Yang, Ewa J Folta‐Stogniew, W. Mark Saltzman, Miriam Amiram, Farren J. Isaacs · 2022 · Proceedings of the National Academy of Sciences
60. Clinical Ramifications of the MHC Family Fc Receptor FcRn
    Derry C. Roopenian, Victor Z. Sun · 2010 · Journal of Clinical Immunology
61. Field flow fractionation for assessing neonatal Fc receptor and Fcγ receptor binding to monoclonal antibodies in solution
    Joey Pollastrini, Thomas M. Dillon, Pavel V. Bondarenko, Robert Chou · 2011 · Analytical Biochemistry
62. FcRn binding properties of an abnormal truncated analbuminemic albumin variant
    Jan Terje Andersen, Muluneh Bekele Daba, Inger Sandlie · 2009 · Clinical Biochemistry
63. Characterization of basolateral-targeting signals in the neonatal Fc receptor
    Estelle E. Newton, Zhen Wu, Neil E. Simister · 2005 · Journal of Cell Science
64. Targeting neonatal Fc receptor: potential clinical applications in pregnancy
    Kenneth Joseph Moise, Dick Oepkes, Enrico Lopriore, Robbert G. M. Bredius · 2022 · Ultrasound in Obstetrics and Gynecology
65. Half‐life extension of single‐domain antibody–drug conjugates by albumin binding moiety enhances antitumor efficacy
    Quanxiao Li, Yu Kong, Yuxuan Zhong, Ailing Huang, Tianlei Ying, Yanling Wu · 2024 · MedComm
66. Revolutionizing Alzheimer's treatment: Harnessing human serum albumin for targeted drug delivery and therapy advancements
    Divya Shastri, Vinit Raj, Sang-Kil Lee · 2024 · Ageing Research Reviews
67. TGEV infection up-regulates FcRn expression via activation of NF-κB signaling
    Jinyue Guo, Fei Li, Shaoju Qian, Dingren Bi, Qigai He, Hui Jin, Rui Luo, Shaowen Li, Xianrong Meng, Zili Li · 2016 · Scientific Reports
68. Improvement of pharmacokinetic properties of therapeutic antibodies by antibody engineering
    Kenta Haraya, Tatsuhiko Tachibana, Tomoyuki Igawa · 2018 · Drug Metabolism and Pharmacokinetics
69. Subcutaneous delivery of an antibody against SARS-CoV-2 from a supramolecular hydrogel depot
    Catherine M. Kasse, Anthony C. Yu, Abigail E. Powell, Gillie A. Roth, Celine S. Liong, C. Jons, Awua Buahin, Caitlin L. Maikawa, Xueting Zhou, S. Youssef et al. · 2023 · Biomaterials Science
70. Population Pharmacokinetic and Pharmacodynamic Analysis of Belimumab Administered Subcutaneously in Healthy Volunteers and Patients with Systemic Lupus Erythematosus
    Herbert Struemper, Mita M. Thapar, David A. Roth · 2017 · Clinical Pharmacokinetics
71. A strategy for bacterial production of a soluble functional human neonatal Fc receptor
    Jan Terje Andersen, Sune F. L. Justesen, Gøril Berntzen, Terje Einar Michaelsen, Vigdis Lauvrak, Burkhard T. Fleckenstein, Søren Buus, Inger Sandlie · 2007 · Journal of Immunological Methods
72. Clinical chemistry of human FcRn transgenic mice
    Carsten Stein, Lothar Kling, Gabriele Proetzel, Derry C. Roopenian, Martin Hrabě de Angelis, Eckhard Wolf, Birgit Rathkolb · 2011 · Mammalian Genome
73. A GLP‐1 receptor agonist conjugated to an albumin‐binding domain for extended half‐life
    Joel Lindgren, Essam Refai, Sergei V Zaitsev, Lars Abrahmsén, Per‐Olof Berggren, Amelie Eriksson Karlström · 2014 · Biopolymers
74. Pharmacokinetics of recombinant bifunctional fusion proteins
    Xiaoying Chen, Jennica L. Zaro, Wei‐Chiang Shen · 2012 · Expert Opinion on Drug Metabolism & Toxicology
75. An Albumin-Oligonucleotide Assembly for Potential Combinatorial Drug Delivery and Half-Life Extension Applications
    Matthias Kuhlmann, Jonas B.R. Hamming, Anders Voldum, Γεωργία Τσακιρίδου, Maja Thim Larsen, Julie S. Schmøkel, Emil Sohn, Konrad Bieńk, David Schaffert, Esben Skipper Sørensen et al. · 2017 · Molecular Therapy — Nucleic Acids
76. Lack of FcRn Impairs Natural Killer Cell Development and Functions in the Tumor Microenvironment
    Diana Cadena Castaneda, Christine Dhommée, Thomas Baranek, Emilie Dalloneau, Laurie Lajoie, Alexandre Valayer, Christophe Arnoult, Marie-Véronique Demattei, Delphine Fouquenet, Christelle Parent et al. · 2018 · Frontiers in Immunology
77. Antibody Expression and Production
    Mohamed Al‐Rubeai · 2011 · Cell engineering
78. Plasma protein-mediated uptake and contradictions to the free drug hypothesis: a critical review
    J Schulz, David M. Stresser, J. Cory Kalvass · 2023 · Drug Metabolism Reviews
79. Intrinsically Disordered Regions in Serum Albumin: What Are They For?
    Литус Екатерина Андреевна, Sergei E. Permyakov, Vladimir Nikolaevich Uversky, Eugene A. Permyakov · 2017 · Cell Biochemistry and Biophysics
80. Distribution of rat neonatal Fc receptor in the principal organs of neonatal and pubertal rats
    Zehua Tian, Brian J. Sutton, Xiaoying Zhang · 2013 · Journal of Receptors and Signal Transduction
81. Albumin fusion with granulocyte-macrophage colony-stimulating factor acts as an immunotherapy against chronic tuberculosis
    Yu-Min Chuang, Liangmei He, Michael L. Pinn, Ya-Chea Tsai, Max A. Cheng, Emily Alice Farmer, Petros C. Karakousis, Chien‐Fu Hung · 2020 · Cellular and Molecular Immunology
82. Human FcRn expression and Type I Interferon signaling control Echovirus 11 pathogenesis in mice
    Alexandra I. Wells, Kalena A. Grimes, Kenneth Kim, Emilie Branche, Christopher J. Bakkenist, William H. DePas, Sujan Shresta, Carolyn B. Coyne · 2021 · PLoS Pathogens
83. Cathepsin B-Overexpressed Tumor Cell Activatable Albumin-Binding Doxorubicin Prodrug for Cancer-Targeted Therapy
    Hanhee Cho, Man Kyu Shim, Suah Yang, Sukyung Song, Yujeong Moon, Jinseong Kim, Youngro Byun, Cheol‐Hee Ahn, Kwangmeyung Kim · 2021 · Pharmaceutics
84. Colostrogenesis: Role and Mechanism of the Bovine Fc Receptor of the Neonate (FcRn)
    Craig R. Baumrucker, Ann L. Macrina, R.M. Bruckmaier · 2021 · Journal of Mammary Gland Biology and Neoplasia
85. Species Differences in Tryptophan Metabolism and Disposition
    Abdulla A.‐B. Badawy, Gilles J. Guillemin · 2022 · International Journal of Tryptophan Research
86. Biodistribution of the recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in rats
    Eva Herzog, Stephen Harris, Claire Henson, Andrew McEwen, Sabrina Schenk, Marc Wolfgang Nolte, Ingo Pragst, Gerhard Dickneite, Stefan Schulte, Sabine Zollner · 2014 · Thrombosis Research
87. Erythrocyte and plasma protein modification in alcoholism: A possible role of acetaldehyde
    Olga V. Tyulina, Valentina D. Prokopieva, А. А. Болдырев, Peter Johnson · 2006 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
88. Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment
    Adnan Moinuddin, Sophie M. Poznanski, Ana L. Portillo, Jonathan K. Monteiro, Ali A. Ashkar · 2024 · Immunological Reviews
89. Albumin-based Drug Delivery Using Cysteine 34 Chemical Conjugates–Important Considerations and Requirements
    Mikael Bjerg Caspersen, Matthias Kuhlmann, Karl Nicholls, Malcolm J. Saxton, Birgitte Andersen, Karen A. Bunting, Jason Cameron, Kenneth Alan Howard · 2017 · Therapeutic Delivery
90. Paraneoplastic Autoimmune Neurological Syndromes and the Role of Immune Checkpoint Inhibitors
    Sophie L. Duong, Harald Prüss · 2022 · Neurotherapeutics
91. Clinical pharmacology considerations for the approval of belimumab for the treatment of adult patients with active lupus nephritis: A regulatory perspective
    Tao Liu, Rosemarie Neuner, Aliza Thompson, Ginto Pottackal, David M. Petullo, Jiang Liu, Nikolay P. Nikolov, Chandrahas G. Sahajwalla, Suresh Doddapaneni, Jianmeng Chen · 2022 · Lupus
92. Human FcRn Transgenic Mice for Pharmacokinetic Evaluation of Therapeutic Antibodies
    Derry C. Roopenian, Gregory J. Christianson, Gabriele Proetzel, Thomas J. Sproule · 2016 · Methods in molecular biology
93. IgG is transported across the mouse yolk sac independently of FcγRIIb
    Mohanty, Sudhasri, Kim, Jonghan, Ganesan, Latha P., Phillips, Gary S., Hua, Keding, Jarjoura, David, Hayton, William L., Robinson, John M., Anderson, Clark L. · 2010 · Journal of Reproductive Immunology
94. Nanotransporters for drug delivery
    Tessa C. Lühmann, Lorenz Meinel · 2016 · Current Opinion in Biotechnology
95. A pan-cancer dye for solid-tumour screening, resection and wound monitoring via short-wave and near-infrared fluorescence imaging
    Mc Larney, Benedict Edward, Sonay, Ali Yasin, Apfelbaum, Elana, Mostafa, Nermin, Monette, Sébastien, Goerzen, Dana, Aguirre, Nicole, Exner, Rüdiger M., Habjan, Christine, Isaac, Elizabeth et al. · 2024 · Nature Biomedical Engineering
96. Therapeutic Plasma Exchange Versus FcRn Inhibition in Autoimmune Disease
    Paola Mina‐Osorio, Minh‐Ha Tran, Ali Aamer Habib · 2023 · Transfusion Medicine Reviews
97. Differential effects of FcRn antagonists on the subcellular trafficking of FcRn and albumin
    Ma, Guanglong, Crowley, Andrew R., Heyndrickx, Liesbeth, Rogiers, Ilse, Parthoens, Eef, Van Santbergen, Jolien, Ober, Raimund J., Bobkov, Vladimir, de Haard, Hans, Ulrichts, Peter et al. · 2024 · JCI Insight
98. Advanced microbiome therapeutics for oral delivery of peptides and proteins: Advances, challenges, and opportunities
    Hitesh P. Gelli, Ruben Vazquez-Uribe, Stephen Timothy Buckley, Jan Terje Andersen, Morten Otto Alexander Sommer · 2025 · Advanced Drug Delivery Reviews
99. Analytical ultracentrifugation with fluorescence detection system reveals differences in complex formation between recombinant human TNF and different biological TNF antagonists in various environments
    Elena Krayukhina, Masanori Noda, Kentaro Ishii, Takahiro Maruno, Hirotsugu Wakabayashi, Minoru Tada, Takuo Suzuki, Akiko Ishii‐Watabe, Masahiko Katô, Susumu Uchiyama · 2017 · mAbs
100. Unraveling the immunopathogenesis of glomerular disease
     Bonny L. Dickinson · 2016 · Clinical Immunology